James Andrews

Jim Andrews serves as senior vice president and CFO of AngioScore.

Previously, he was the vice president of finance and CFO of Orquest, an innovative medical technology company dedicated to setting new standards of care in orthopedics through biological solutions. From 1995 to 2004, Andrews held a variety of positions with Orquest and was an integral member of the team that sold Orquest to DePuy Acromed, a wholly owned subsidiary of Johnson & Johnson.

He also founded Andrews and Associates, a financial management consulting firm specializing in senior management consulting in the life science industry.

He started his career working four years in Big Four public accounting, where he became a certified public accountant.

Andrews has a BS in business with an accounting specialization from the University of Colorado

James Andrews is the SVP & CFO at AngioScore. With a background in Biotechnology, James Andrews has a rich history of leadership and innovation.James Andrews studied BS Business & Accounting at University of Colorado. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.